Download new breakthroughs increase the efficiency of Critical Quality Attribute (CQA) testing and allow for a Multi- Attribute Method (MAM) compendium
Production of therapeutic monoclonal antibodies (mAbs) relies on living cells or organisms. Characterisation of the structure of the mAb is extremely complicated due to the diversity of modifications that can occur during the production, storage and formulation process. It can be challenging to establish well-characterised antibody therapeutics and meet current regulatory expectations.
Download Agilent’s Biopharma CQA Efficiencies Compendium and explore the possibility of using multidimensional technologies such as: 2D-LC, high-resolution Mass Spectrometry (MS), novel chemistries and columns to enhance the efficiency in Critical Quality Attributes (CQAs) analysis, the possibility of measuring multiple attributes simultaneously to decrease overall analysis time and how to obtain faster turn-around results.